These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [How to improve the system of classification and diagnosis of depressive syndrome]. Miyaoka H Seishin Shinkeigaku Zasshi; 2013; 115(3):285-9. PubMed ID: 23691815 [TBL] [Abstract][Full Text] [Related]
43. [Multisystem atrophy]. Elkin MN; Iakhno NN Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(3):93-7. PubMed ID: 8992848 [No Abstract] [Full Text] [Related]
44. Why the Hamilton Depression Rating Scale endures. Corruble E; Hardy P Am J Psychiatry; 2005 Dec; 162(12):2394; author reply 2397-8. PubMed ID: 16330615 [No Abstract] [Full Text] [Related]
45. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Tulen JH; Volkers AC; van den Broek WW; Bruijn JA J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207 [No Abstract] [Full Text] [Related]
46. [A case report of Shy-Drager disease]. Stepień A; Maksymiuk G Neurol Neurochir Pol; 1997; 31(2):335-41. PubMed ID: 9380263 [TBL] [Abstract][Full Text] [Related]
47. [Acute bilateral recurrent laryngeal nerve paralysis, a symptom of Shy-Drager syndrome]. Laubert A HNO; 1988 Jul; 36(7):290-2. PubMed ID: 3209429 [TBL] [Abstract][Full Text] [Related]
48. Verapamil may cause depression. Dassylva B Can J Psychiatry; 1993 May; 38(4):299-300. PubMed ID: 8518988 [No Abstract] [Full Text] [Related]
49. The epidemiology of depression and the evolution of treatment. Hirschfeld RM J Clin Psychiatry; 2012; 73 Suppl 1():5-9. PubMed ID: 22951236 [TBL] [Abstract][Full Text] [Related]
50. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. O'Donovan C; Garnham JS; Hajek T; Alda M J Affect Disord; 2008 Apr; 107(1-3):293-8. PubMed ID: 17850879 [TBL] [Abstract][Full Text] [Related]
55. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles]. Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975 [No Abstract] [Full Text] [Related]
56. What is the best approach to management of acute depression in bipolar disorder? Joffe RT; MacQueen GM; Young LT J Psychiatry Neurosci; 2000 Nov; 25(5):516. PubMed ID: 11109302 [No Abstract] [Full Text] [Related]
57. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK; Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810 [TBL] [Abstract][Full Text] [Related]
58. Psychiatric disturbances in the Shy-Drager syndrome. Rizzoli AA Br J Psychiatry; 1986 Apr; 148():484. PubMed ID: 3730724 [No Abstract] [Full Text] [Related]
59. International consensus group on depression prevention in bipolar disorder. Frye MA; Ha K; Kanba S; Kato T; McElroy SL; Özerdem A; Vázquez G; Vieta E J Clin Psychiatry; 2011 Oct; 72(10):1295-310. PubMed ID: 22075097 [No Abstract] [Full Text] [Related]